slides · global inventory
Consultants Gambit
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 39,432
Current window 7,471-7,500
Pages 1,315
Rows per page 30
Arc
7,471-7,500 of 39,432
14
The table highlights the 'Most influential position' in green for each column.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
15
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
16
Data derived from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
17
Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
18
Data derived from L.E.K. 2021 and 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
19
Data based on a survey of 120 respondents regarding sales representative outreach/presence.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
20
Data from L.E.K. 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
21
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
22
Data from L.E.K. 2021, 2022 APAC Hospital Priorities Survey.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
23
The slide uses a stacked bar chart to visualize survey data regarding hospital access restrictions for pharmaceutical sales representatives.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
24
The slide combines survey data on digital tool acceptance with epidemiological data on COVID-19 cases to justify the shift toward digital engagement.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
25
Survey data from 120 respondents in 2021 and 2022.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
26
Data based on a survey of 120 respondents.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
27
Hospital Priorities 2022 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
28
The slide uses stacked bar charts to represent survey data on hospital financial health.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
29
The slide uses a stacked bar chart for sustainability duration and a grouped bar chart for impact factors.Hospital Priorities 2022 China Edition: Strategic Implications for Pharma Companies · L.E.K.
Consulting deck Strategy consulting Beat · Solution & Approach1 hit
02
The slide uses stacked bar charts to visualize the composition of the survey sample.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
03
NRDL=National Reimbursement Drug List; VBP=volume-based procurementHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Situation & Context1 hit
04
The table includes bilingual (English/Chinese) labels for spending categories.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
05
The chart highlights top priorities for hospitals regarding pharma support, with a specific callout regarding NRDL negotiation and VBP impact on drug costs.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
06
Data from L.E.K. 2023 APAC Hospital Priorities Survey (N=100).Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
07
The slide uses a consistent color-coded legend for years (2021, 2022, 2023) across three bar charts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
08
NRDL = National Reimbursement Drug List. Data from L.E.K. APAC Hospital Priorities Survey.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
09
The slide uses a stacked bar chart approach to visualize survey data regarding prescription outflow shifts.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
10
The chart shows a clear shift toward higher acceptance of digital engagement in 2023 compared to 2022 across all hospital segments.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
11
The slide uses a bilingual (Chinese/English) format for labels.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
12
Includes a specific callout explaining a spike in privacy concerns due to China's PIPL law.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
13
The slide uses a stacked bar chart approach to visualize survey responses regarding financial health.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Golden Circle1 hit
14
The slide uses a numbered list to structure key strategic inquiries.Hospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Problem & ComplicationLoop · Aha Moment1 hit
15
Hospital Priorities 2023 China Edition: Strategic Implications for Pharma CompaniesHospital Priorities 2023 China Edition: Strategic Implications for Pharma Companies · LEK
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Golden Circle1 hit